top of page

Negative symptoms Impacting Quality of Life and Functioning
 

Presented By: 

Ofer Agid, MD

Associate Professor, Department of Psychiatry

CAMH and the University of Toronto

Toronto, ON

Christoph Correll, MD

Professor of Psychiatry and Molecular Medicine
The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Hempstead, NY

Ric Procyshyn, BSc(Pharm), MSc, PharmD, PhD

University of British Columbia

Principal Investigator

BC Mental Health and Substance Use Services Research Institute

Vancouver, BC

Learning Objectives: 

  • ​Consider the impact of negative symptoms on functioning and quality of life

  • Evaluate the pharmodynamic and pharmacokinetic profile of antipsychotic medications in relation to negative symptoms and side effect burden

  • Identify appropriate patients whose treatment plan should be re-evaluated in order to optimize care

Originally Presented at 2022 Negative Symptoms Webinar​​

This initiative has been sponsored in part by Abbvie, through an educational grant.

Canadian Consortium for

Early Intervention in Psychosis

Hamilton, ON

905-525-8213

Contact Us: admin@epicanada.org​

Become a Friend of EPI Canada!

bottom of page